Article

Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour…

medRxiv · 2023 · Kennedy, P. T.; Saulters, E. L.; Duckworth, A. D.; Lim, Y. J.; Woolley, J. F.; Slupsky, J. R.; Cragg, M. S.; Ward, F. J.; Dahal, L. N.

Key facts

Title Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunity
First author Kennedy, P. T.; Saulters, E. L.; Duckworth, A. D.; Lim, Y. J.; Woolley, J. F.; Slupsky, J. R.; Cragg, M. S.; Ward, F. J.; Dahal, L. N.
Journal medRxiv
Published Jun 7, 2023
DOI 10.1101/2023.06.05.543731
Product codes mentioned GIA, MVU

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature